COMP <GO>
HQY vs TSLA // EV/EBITDA & P/E VALUATION
HealthEquity Inc. (NASDAQ) VS. Tesla, Inc. (NASDAQ) • 15-METRIC TALLY: HQY 11
— TSLA 3
▲ EV/EBITDA & P/E VALUATION LEADER: HQY
LAST: $102.47 (+1.10%) • MKT CAP: $8.38B
valuation
27.8x
LAST: $399.81 (-0.87%) • MKT CAP: $1.58T
valuation
199.0x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (HQY VS. TSLA)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | HQY | TSLA | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 69.50% | 19.29% | +50.21 | HQY | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 9.30% | 3.39% | +5.91 | HQY | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | 27.8x | 199.0x | -171.24 | HQY | /valuation <GO> |
| Free Cash Flow Yield | 5.43% | 0.21% | +5.22 | HQY | /fcf-yield <GO> |
| Operating Margin | 24.60% | 3.35% | +21.25 | HQY | /operating-margins <GO> |
| Net Profit Margin | 16.40% | 3.11% | +13.29 | HQY | /net-margins <GO> |
| Revenue Growth (YoY) | 9.50% | 8.30% | +1.20 | HQY | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 4.86 | 15.35 | -10.49 | TSLA | /balance-sheet <GO> |
| Piotroski F-Score Quality | 9/9 | 5/9 | +4.00 | HQY | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 6.80% | 8.72% | -1.92 | HQY | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 66.3 | 60.9 | +5.47 | HQY | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.96 | 1.89 | -0.93 | TSLA | /macro-sensitivity <GO> |
| Forward P/E Multiple | 36.3x | 174.4x | -138.13 | HQY | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $8.38B | $1.58T | -$1.57T | TSLA | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | HQY REV | TSLA REV | HQY GROSS % | TSLA GROSS % | HQY FCF | TSLA FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $1.31B | $94.83B | 69.5% | 18.0% | $455.1M | $6.22B |
| FY 2024 | $1.20B | $97.69B | 64.8% | 17.9% | $337.8M | $3.58B |
| FY 2023 | $999.6M | $96.77B | 44.0% | 18.3% | $197.8M | $4.36B |
| FY 2022 | — | $81.46B | — | 25.6% | — | $7.57B |
| FY 2021 | — | $53.82B | — | 25.3% | — | $5.01B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
HQY // BETA 0.96
TSLA // BETA 1.89